Pfizer's stock has hit bottom and could see a boost from bird flu fears.Covid-related sales now account for less than 15% of Pfizer's total revenues, de-risking the investment story.Pfizer is cutting ...
Source LinkPfizer's stock has hit bottom and could see a boost from bird flu fears.Covid-related sales now account for less than 15% of Pfizer's total revenues, de-risking the investment story.Pfizer is cutting ...
Source Link
Comments